D.E. Shaw & Co
PIII icon

D.E. Shaw & Co’s P3 Health Partners PIII Stock Holding History

D.E. Shaw & Co’s Portfolio PIII Stock Details PIII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-7,474
Closed -$3.68M – 5643
2021
Q3 		$3.68M Hold
7,474
– – ﹤0.01% 2414
2021
Q2 		$3.7M Buy
+7,474
New +$3.67M ﹤0.01% 2310

Other funds holding PIII

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NIP
Nicholas Investment Partners Rancho Santa Fe, California $1.39B AUM 97.11% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
SMH
Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
RCG
Rock Creek Group Washington, District of Columbia $988M AUM 8.89% 1-Year Est. Return

D.E. Shaw & Co's PIII Position: Q4 2021 in Review

D.E. Shaw & Co sold out of P3 Health Partners (PIII) in Q4 2021, closing a stake of 7,474 shares — an estimated $3.68M sold.

D.E. Shaw & Co first reported a position in PIII in Q2 2021 and held it in 2 quarters. The position peaked at $3.7M in Q2 2021. 24 funds tracked by Wall St. Rank hold PIII as of Q4 2021.

  • D.E. Shaw & Co reported no remaining P3 Health Partners position as of Q4 2021 after selling out during the quarter.
  • D.E. Shaw & Co sold 7,474 P3 Health Partners shares in Q4 2021, an estimated $3.68M.
  • D.E. Shaw & Co first reported a position in P3 Health Partners in Q2 2021 and held it in 2 quarters.
  • D.E. Shaw & Co's P3 Health Partners position peaked at $3.7M in Q2 2021.
  • 24 funds tracked by Wall St. Rank held P3 Health Partners as of Q4 2021.

Based on D.E. Shaw & Co's 13F filing for Q4 2021, filed 14 Feb 2022.